Atlas Trials

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Clinical trial NCT01829464 · TERMINATED

Trial details

NCT number
NCT01829464
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes
Start date
2013-05-01
Primary completion
2014-02-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.